1-3 of 3
Dave M. Yamauchi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer

Jeffrey Y. C. Wong, David Z. Chu, Lawrence E. Williams, Dave M. Yamauchi, David N. Ikle, Cheuk S. Kwok, An Liu, Sharon Wilczynski, David Colcher, Paul J. Yazaki, John E. Shively, Anna M. Wu, Andrew A. Raubitschek
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5014–5021.
https://doi.org/10.1158/1078-0432.CCR-03-0576
Published: 05 August 2004
View article titled, Pilot Trial Evaluating an <sup>123</sup>I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer
Open the PDF for Pilot Trial Evaluating an <sup>123</sup>I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer in another window
Journal Articles

A Phase I Trial of 90Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer

Jeffrey Y. C. Wong, Stephen Shibata, Lawrence E. Williams, Cheuk S. Kwok, An Liu, David Z. Chu, Dave M. Yamauchi, Sharon Wilczynski, David N. Ikle, Anna M. Wu, Paul J. Yazaki, John E. Shively, James H. Doroshow, Andrew A. Raubitschek
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5842–5852.
Published: 15 December 2003
View article titled, A Phase I Trial of <sup>90</sup>Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer
Open the PDF for A Phase I Trial of <sup>90</sup>Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer in another window
Journal Articles

A Phase I Radioimmunotherapy Trial Evaluating 90Yttrium-labeled Anti-Carcinoembryonic Antigen (CEA) Chimeric T84.66 in Patients with Metastatic CEA-producing Malignancies

Jeffrey Y. C. Wong, David Z. Chu, Dave M. Yamauchi, Lawrence E. Williams, An Liu, Sharon Wilczynski, Anna M. Wu, John E. Shively, James H. Doroshow, Andrew A. Raubitschek
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (10): 3855–3863.
Published: 01 October 2000
View article titled, A Phase I Radioimmunotherapy Trial Evaluating <sup>90</sup>Yttrium-labeled Anti-Carcinoembryonic Antigen (CEA) Chimeric T84.66 in Patients with Metastatic CEA-producing Malignancies
Open the PDF for A Phase I Radioimmunotherapy Trial Evaluating <sup>90</sup>Yttrium-labeled Anti-Carcinoembryonic Antigen (CEA) Chimeric T84.66 in Patients with Metastatic CEA-producing Malignancies in another window